MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

A long-awaited study commissioned by the FDA has muddied the path forward on how to reduce racial bias in pulse oximeter ...

In the child welfare system, the threshold at which a drug test is considered positive varies widely from one jurisdiction to ...

We tested powders from Clean Simple Eats, Equate, Premier Protein, Ritual, and Truvani. Our results show it’s possible to ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...

This valuable study links psychological theories of chunking with a physiological implementation based on short-term synaptic plasticity and synaptic augmentation. The theoretical derivation for ...

Discover our testers’ and sleep experts' favorite pillows for back sleepers, including the best down, memory foam, wedge, and ...